It is well established that natural killer cells(NKC)are the body’s first line of defense againstmalignant growth, and NK cytotoxicity is regulat-ed by severa
Background:We recently showed HER2-positive breast cancers are less likely to respond to neoadjuvant anthracycline chemotherapy.Here,we investigated whether HER